SCHEMBL19797406

SCHEMBL19797406

CC1(C)c2ccccc2N(c2cc(-c3cncc(P(=O)(c4ccccc4)c4ccccc4)c3)cc(-n3c4ccccc4c4ccccc43)c2)c2ccccc21

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 1/20 0.33
▸ HDAC4 P56524 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29275150 0.87 KDM4E (0.39) NPSR1HDAC4
SCHEMBL30961239 0.87 KDM4E (0.39) NPSR1HDAC4
SCHEMBL19797408 0.83 NPSR1 (0.32) NPSR1
SCHEMBL19797409 0.83 NPSR1 (0.32) NPSR1
SCHEMBL19797403 0.83 ALDH1A1 (0.37) —
SCHEMBL14595501 0.82 KDM4E (0.39) NPSR1HDAC4
SCHEMBL19797410 0.82 — —
SCHEMBL19805130 0.82 BACE1 (0.33) —
SCHEMBL19797407 0.81 NPSR1 (0.32) NPSR1
SCHEMBL13231536 0.78 KDM4E (0.43) NPSR1HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10388889-B2 Substituted phosphines as components of organic light-emitting devices SAMSUNG DISPLAY CO., LTD. (KR) 2019-08-20 — — US disclosed
US-20180026206-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-25 — — US disclosed
US-20180026206-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180026206-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CYP1A1, CYP1B1 NPSR1 4005/4885HDAC4 3360/4885
US-10388889-B2 Substituted phosphines as components of organic light-emitting devices CRY1, CRY2, PER2 NPSR1 2792/4885HDAC4 4717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback